UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LGI
4901
Lazard Global Total Return & Income Fund
LGI
$240M
| $1.65M | ﹤0.01% |
103,537
+10,625
| +11% | +$180K |
|
4902
Myers Industries
MYE
$1.29B
| $1.65M | ﹤0.01% |
149,564
+106,901
| +251% | +$1.29M |
|
|
PFC
4903
DELISTED
Premier Financial Corp. Common Stock
PFC
| $1.65M | ﹤0.01% |
64,525
+24,242
| +60% | +$632K |
|
4904
Avita Medical
RCEL
$240M
| $1.65M | ﹤0.01% |
128,630
+110,824
| +622% | +$1.31M |
|
|
THW
4905
abrdn World Healthcare Fund
THW
$551M
| $1.65M | ﹤0.01% |
149,511
-9,797
| -6% | -$119K |
|
4906
CALL
DaVita
DVA
$11.7B
| $1.65M | ﹤0.01% |
+11,000
| New | +$1.72M |
|
4907
Theravance Biopharma
TBPH
$877M
| $1.64M | ﹤0.01% |
174,245
+143,488
| +467% | +$1.31M |
|
4908
Tema ETF Trust Tema Heart & Health ETF
HRTS
$55.5M
| $1.64M | ﹤0.01% |
56,682
+39,844
| +237% | +$1.28M |
|
4909
PUT
Reddit
RDDT
$31.1B
| $1.63M | ﹤0.01% |
+10,000
| New | +$1.23M |
|
4910
CALL
PVH
PVH
$4.04B
| $1.63M | ﹤0.01% |
+15,400
| New | +$1.58M |
|
|
FFC
4911
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$782M
| $1.63M | ﹤0.01% |
104,771
+714
| +0.7% | +$11.4K |
|
4912
Rezolute
RZLT
$452M
| $1.63M | ﹤0.01% |
331,799
+329,756
| +16,141% | +$1.66M |
|
4913
PUT
JetBlue
JBLU
$2.29B
| $1.62M | ﹤0.01% |
+206,700
| New | +$1.4M |
|
4914
Medifast
MED
$141M
| $1.62M | ﹤0.01% |
92,182
+85,866
| +1,359% | +$1.59M |
|
4915
Red Cat Holdings
RCAT
$1.4B
| $1.62M | ﹤0.01% |
126,313
+88,310
| +232% | +$539K |
|
4916
PUT
Asana
ASAN
$2.13B
| $1.62M | ﹤0.01% |
+80,000
| New | +$1.27M |
|
4917
Spire Global
SPIR
$555M
| $1.62M | ﹤0.01% |
115,172
+94,921
| +469% | +$1.16M |
|
4918
PUT
Ally Financial
ALLY
$13.3B
| $1.62M | ﹤0.01% |
45,000
| – | – |
|
4919
CALL
United Rentals
URI
$72.4B
| $1.62M | ﹤0.01% |
+2,300
| New | +$1.87M |
|
4920
Park Aerospace
PKE
$819M
| $1.62M | ﹤0.01% |
110,500
-85,710
| -44% | -$1.23M |
|
4921
iShares MSCI Global Sustainable Development Goals ETF
SDG
$175M
| $1.62M | ﹤0.01% |
22,602
+4,052
| +22% | +$316K |
|
4922
Health Catalyst
HCAT
$128M
| $1.61M | ﹤0.01% |
228,255
+124,922
| +121% | +$995K |
|
4923
Seneca Foods Class A
SENEA
$1.21B
| $1.61M | ﹤0.01% |
20,284
+13,303
| +191% | +$915K |
|
4924
McEwen Inc
MUX
$1.18B
| $1.61M | ﹤0.01% |
206,588
+187,687
| +993% | +$1.7M |
|
|
MCN
4925
Madison Covered Call & Equity Strategy Fund
MCN
$118M
| $1.61M | ﹤0.01% |
239,337
-105,400
| -31% | -$734K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.